Trial intelligence / Profile preview

Tirofiban Facilitated PCI in STEMI

NCT00611169Phase 4Completed

Sponsor
Samsung Medical Center
Start
Jan 2006
Primary completion
Feb 2007
Modality
Small Molecules
01

Overview

A Phase 4 trial of tirofiban in ST-segment elevation myocardial infarction (STEMI), sponsored by Samsung Medical Center. Started Jan 2006; status: completed.

02

Drugs

tirofiban
03

Conditions

ST-segment elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT00611169.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00611169.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call